Verified email-pattern data for Entero Therapeutics (Nasdaq: Ento) is currently limited. You can still use the company insights and contact sections below.
Entero Therapeutics, Inc., is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The Company’s programs address significant unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency. For more information visit www.enterothera.com.
Entero Therapeutics is currently advancing a therapeutic development pipeline populated with multiple clinical stage programs built around its two proprietary technologies – niclosamide, an oral small molecule with anti-viral and anti-inflammatory properties, and the biologic adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients.
Entero’s niclosamide portfolio is led by three clinical programs: FW-COV, for COVID-19 gastrointestinal infections; FW-UP, for ulcerative proctitis (UP) and ulcerative proctosigmoiditis; and FW-ICI-AC, for Grade 1 and Grade 2 Immune Checkpoint Inhibitor-associated colitis and diarrhea in advanced oncology patients. Two additional formulations of niclosamide, FW-UC (ulcerative colitis) and FW-CD (Crohn’s disease) are expected to enter the clinic in 2022 and 2023, respectively.
Entero is also advancing FW-EPI (adrulipase) for the treatment of exocrine pancreatic insufficiency (EPI) in patients with cystic fibrosis and chronic pancreatitis.
The Company is headquartered in Boca Raton, Florida with clinical operations in Hayward, California. For more information visit www.firstwavebio.com.
Company Details
- Employees
- 9
- Founded
- -
- Address
- 777 Yamato Road,
- Industry
- Pharmaceutical Manufacturing
- Website
- https://www.enterothera.com
- Keywords
- Gastrointestinal diseases, Gastrointestinal, GI diseases, GI health, Celiac, Celiac disease, Gluten Intolerance, Gluten-free diet, Gluten-free, Gluten, Latiglutenase, Gastroparesis, Capeserod, Lipase, Pancreatitis, Cystic Fibrosis, Adrulipase, Therapeutics.
- HQ
- Boca Raton, FL
Entero Therapeutics (Nasdaq: Ento) Questions
Entero Therapeutics (Nasdaq: ENTO)'s website is https://www.enterothera.com
Entero Therapeutics (Nasdaq: ENTO)'s LinkedIn profile is https://www.linkedin.com/company/enterothera
Entero Therapeutics (Nasdaq: ENTO) has
9 employees.
View email and phone details for 9
employees at Entero Therapeutics (Nasdaq: ENTO).
Entero Therapeutics (Nasdaq: ENTO)'s industry is
Pharmaceutical Manufacturing
Entero Therapeutics (Nasdaq: ENTO)'s top competitors are
An2 Therapeutics,
Virometix Ag,
Plus Therapeutics, Inc.,
Mei Pharma,
Gritstone Bio,
Catamaran Bio,
Vbi Vaccines Inc.,
Synlogic,
Inhibikase Therapeutics, Inc.,
Athersys.
Entero Therapeutics (Nasdaq: ENTO)'s categories are Pharmaceutical Manufacturing
Entero Therapeutics (Nasdaq: ENTO)'s founding year is 2014
Explore related pages
Entero Therapeutics (Nasdaq: ENTO) company profile
Entero Therapeutics (Nasdaq: ENTO) management contacts
Related company profiles:
Companies like Entero Therapeutics (Nasdaq: ENTO)
Top Entero Therapeutics (Nasdaq: ENTO) Employees
-
Martin Krusin
Senior Vice President, Corporate Development At Entero Therapeutics Inc.
Brooklyn, New York, United States, United States
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.